Vytrus Biotech (XMAD:VYT) Interest Expense: €-0.05 Mil (TTM As of Dec. 2025)


XMAD:VYT Vytrus Biotech SA XMAD:VYT
69 GF Score
Price €17.40
GF Value €5.55
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech Interest Expense?

Vytrus Biotech XMAD:VYT -0.57% 69 Interest Expense is €-0.05 Mil as of Dec. 2025. GuruFocus rates XMAD:VYT with a GF Score™ of 69/100 and a GF Value™ of €5.55 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vytrus Biotech's interest expense for the six months ended in Dec. 2025 was € -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vytrus Biotech's Operating Income for the six months ended in Dec. 2025 was € 1.55 Mil. Vytrus Biotech's Interest Expense for the six months ended in Dec. 2025 was € -0.00 Mil. Vytrus Biotech's Interest Coverage for the quarter that ended in Dec. 2025 was 386.50. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vytrus Biotech  (XMAD:VYT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vytrus Biotech's Interest Expense for the six months ended in Dec. 2025 was €-0.00 Mil. Its Operating Income for the six months ended in Dec. 2025 was €1.55 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was €1.54 Mil.

Vytrus Biotech's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*1.546/-0.004
=386.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Vytrus Biotech Interest Expense Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Interest Expense Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial -0.12 -0.19 -0.14 -0.10 -0.05

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.07 -0.04 -0.05 -0.00
XMAD:VYT
69GF Score
Vytrus Biotech SA XMAD:VYT
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-0.05 Mil mean?
Vytrus Biotech (XMAD:VYT) has a Interest Expense of €-0.05 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vytrus Biotech and its competitors.
Is Vytrus Biotech's Interest Expense too high?
Vytrus Biotech's current Interest Expense is €-0.05 Mil. Overall, Vytrus Biotech has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's Interest Expense compare to VRTX and REGN?
Vytrus Biotech's Interest Expense of €-0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Vytrus Biotech and its competitors. Vytrus Biotech's current Interest Expense is €-0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (XMAD:VYT) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.55, compared to a current price of €17.40 — trading 213.5% above its estimated fair value. The current Interest Expense is €-0.05 Mil. Vytrus Biotech's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Vytrus Biotech (XMAD:VYT), the current Interest Expense is €-0.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (XMAD:VYT) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €17.40 is trading 213.5% above its estimated GF Value™ of €5.55. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for XMAD:VYT:

  • Interest Expense: €-0.05 Mil
  • GF Value™: €5.55 vs. price of €17.40 (213.5% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the XMAD:VYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges V5P:Germany
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
69GF Score

Get the complete analysis for XMAD:VYT

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.40
Price
€5.55
GF Value